|
Cancer type | Gene involved | Function of ROS | Description | References |
|
Acute myeloid leukemia | TIGAR | Tumor suppressor | Knockdown of TIGAR promoting ROS-mediated apoptosis and antiproliferation | [311] |
NOX | Tumor promoter | Activation of NOX increases extracellular ROS level promoting the proliferation of acute myeloid leukemia blasts | [312] |
Breast cancer | p53 | Tumor suppressor | p53 activation induced by ROS can promote necrosis and apoptosis of cancer cells | [313] |
SOD2 | Tumor promoter | Upregulation of SOD2 induces elevated ROS to sustain AMPK-activated signal to promote aerobic glycolysis and malignant transformation | [314] |
ZEB1; GPX4 | Tumor promoter | ZEB1 inhibits transcription of GPX4, increases ROS accumulation and EMT, which promote breast cancer progression | [315] |
Colorectal cancer | HIF-2α | Tumor suppressor | Activated HIF-2α induces ROS production by an iron-dependent pathway which led colorectal cancer cell death | [316] |
ANGPTL4; NOX4 | Tumor promoter | ANGPTL4/NOX4 axis maintains the metastatic ability of colorectal cancer cells via increasing ROS, MMP1, and MMP9 levels | [317] |
Glioblastoma | PRDX3 | Tumor suppressor | Prohibitin maintains the stability of PRDX3 to reduce the production of ROS, maintain glioblastoma stemness and promote the resistance of gliomas stem-like cells to radiotherapy | [318] |
TRAP1; SIRT3 | Tumor suppressor | TRAP1 cooperate with SIRT3 to reduce ROS production and promotes stress adaptation of glioblastoma cancer stem cells | [319] |
Gastric cancer | NNT | Tumor suppressor | NNT deficiency can significantly reduce NADPH and significantly induce ROS production and apoptosis under stress. | [320] |
GRIM-19; Nrf2 | Tumor promoter | GRIM-19 deficiency accelerates gastric cancer metastasis via abnormal oxidative stress and ROS-driven Nrf2 activation | [321] |
Hepatocellular carcinoma | UBQLN1; PGC1β | Tumor suppressor | Elevated expression of UBQLN1 induces PGC1β degradation to promote sorafenib resistance of hepatocellular carcinoma cells by reducing mitochondrial ROS production | [322] |
PKCλ/ι; Nrf2 | Tumor promoter | Loss of PKCλ/ι induces ROS generation promoting hepatocellular carcinoma in a Nrf2-dependent manner | [323] |
Lung cancer | IL-15; mTOR | Tumor promoter | NK cells activate thioredoxin system through IL-15/mTOR axis to adapt to high ROS level in tumor microenvironment | [324] |
AK4; HIF-1α | Tumor promoter | Upregulation of AK4 enhances expression of HIF-1α through increasing ROS production, and then EMT was induced in hypoxia condition | [325] |
AIM2; MAPK/ERK; MFN2 | Tumor promoter | Knockdown of AIM2 upregulates MFN2 and enhances the mitochondrial fusion, resulting in the reduction of mitochondrial ROS production, which in turn induces the inactivation of the MAPK/ERK pathway and hinders the progress of non-small cell lung cancer | [326] |
Nestin; Keap1; Nrf2; | Tumor suppressor | Nestin competed with Nrf2 for binding to Keap1, leading to Nrf2 escape and downstream antioxidant gene expression, which promotes the resistance of NSCLC to oxidative stress | [327] |
Melanoma | ANGPT2 | Tumor suppressor | Silence of Angpt2 expression significantly increases the level of intracellular ROS and activation of downstream MAPK pathway, thus resulting in the metastatic colonization of melanoma | [328] |
Akt | Tumor promoter | Akt overexpression can induce the expression of NOX4, increase the level of ROS, increase the expression of VEGF, increase angiogenesis, and promote the aerobic glycolysis of melanoma cells | [329] |
Ovarian cancer | RAD51 | Tumor promoter | Loss of RAD51 accelerates mitochondrial ROS accumulation and DNA damage which can be weakened by treatment of antioxidant N-acetylcysteine | [330] |
Pancreas cancer | UCP2; Akt; mTOR | Tumor suppressor | Inhibition of UCP2 plays an anticarcinogenic role in pancreatic adenocarcinoma cells via activating ROS/Akt/mTOR axis | [331] |
Renal cell carcinoma | TAZ; EMP1; NOX4; | Tumor suppressor | Nuclear translocation of TAZ upregulates EMP1 expression, thereby increasing the mRNA level of NOX4 and inducing ferroptosis of renal cell carcinoma cells via elevated lipid ROS | [332] |
|